This leads to an increased expression of PD-L1 on the tumor cells’ surface and subsequently, to the negative regulation of antitumor immunity.44 However, tumor intrinsic alterations of the INF-γ signaling pathway reduce the expression of PD-L1, thereby promoting resistance to ICI.45 The gene discussed is CD274; the disease is neoplasm.